Confirmation of CFO Board Appointment

Summary by AI BETAClose X

Feedback plc confirms the appointment of Chief Financial Officer Emma Oswick (Stuart) to its Board of Directors, effective immediately. Ms. Oswick joined the company in November 2025, bringing extensive experience in subscription-led technology businesses and a proven track record in financial performance optimization and strategic change. Her directorships in the last five years include Osmia Consulting Limited, Argentis Properties Limited, and the Chartered Institute of Marketing, with past roles at Dynata Global UK Ltd and E-Rewards Bidco Limited. The CEO expressed confidence that Ms. Oswick's input will strengthen the company's capabilities as Bleepa is positioned to meet growing demands for digital transformation in healthcare.

Disclaimer*

Feedback PLC
16 February 2026
 

 

Feedback plc

 

Directorate Change

 

Confirmation of CFO Board Appointment

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical infrastructure specialist, confirms that further to the announcement of 20 October 2025, that Chief Financial Officer ("CFO") Emma Oswick (Stuart) has been appointed to the Company's Board of Directors, effective from today.

 

Emma joined the Company in November 2025, bringing a background of extensive experience in subscription-led technology businesses, having most recently served as Interim CFO at Energy Aspects. She is passionate about the sector and technology's role in process improvement and positioning for growth. Emma has a proven track record in driving strategic change, optimising financial performance, and developing high-performing teams. She also has considerable M&A and integration experience and is a Chartered Accountant, having qualified with PwC.

 

Further Information:

The following additional information is provided in accordance with Rule 17 and Schedule Two Paragraph (g) of the AIM Rules for Companies:

 

Emma Jane Stuart (née Oswick), aged 54, holds or has held the following directorships in the last five years:

 

Current directorships

Past directorships within the last five years

Osmia Consulting Limited

Dynata Global UK Ltd

Argentis Properties Limited

E-Rewards Bidco Limited

Chartered Institute of Marketing


 

Save for the information disclosed above, there is no other information in relation to Emma Oswick that is required to be disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AІM Rules for Companies.

 

Dr Tom Oakley, CEO of Feedback plc, said: "We are delighted to confirm Emma's position on the Board. She has fully immersed herself in Feedback since joining in November with her input and direction further strengthening our capabilities at this critical stage of the Company's evolution - with Bleepa strongly positioned to fulfil the growing requirements for innovative solutions as the healthcare system and government spending focus on digital transformation."

 

--Ends--

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Emma Oswick, CFO

+44 (0) 20 3997 7634

IR@fbk.com

 


Panmure Liberum Limited (NOMAD and Broker)

Emma Earl/Mark Rogers (Corporate Finance)

Rupert Dearden (Corporate Broking)

+44 (0)20 7886 2500

 


Walbrook PR Ltd;

Tel: 020 7933 8780 or feedbackplc@walbrookpr.com

Nick Rome/Marcus Ulker

07748 325 236 or 07867 984 082

 

 

About Feedback plc

 

Feedback plc is the strategic partner to unlock productivity in health and care through digital connectivity and asynchronous collaboration. With proven expertise in system integration, we enable teams to work flexibly, share information securely, and deliver care more efficiently.

 

Bleepa® is an award-winning collaboration platform that improves the quality and productivity of patient pathways enabling health and care organisations to hit targets with their existing clinical workforce. We achieve this by connecting digital infrastructure across systems, enabling asynchronous working, reducing geographic barriers and removing unnecessary appointments.

 

Bleepa supports the shift from analogue to digital and from hospital to community-based care, by uniting essential data and teams to enhance clinical decision making and enable better coordinated care.

 

The Company has a number of growth opportunities domestically and internationally across a range of public and private healthcare markets including the NHS. Our highly scalable software-as-a-service (SaaS) based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.

 

https://fbk.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Feedback (FDBK)
UK 100

Latest directors dealings